3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Thyroid Diseases
1
Interventions
selpercatinib
3
repotrectinib
1
pembrolizumab
1
cabozantinib
1
binimetinib
1
Thyroxine
1
Thyroid (USP)
1
Sorafenib
1
Observation
1
Metformin
1
Iodine-131
1
Fluorescein
1
Everolimus
1
Data Collection
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thyroid Diseases
×
Thyroid (USP)
×
1 year
×
Clear all
NCT07239674
2025-11-20
DELTA
West China Hospital
Phase 3
Not yet recruiting
646 enrolled